Mikrogen Diagnostik recomLine Bordetella Pertussis IgA Lateral Strip Test Kit

Bordetella pertussis is the main agent of the „whooping cough“, a disease often lasting for weeks til months. The passive immunoprotection transferred from mother to fetus is usually incomplete or inexistent. Therefore especially infants are imperiled by apnea (stop breathing) which can lead to death. Mild courses can be caused by related agents i.e. B. parapertussis. Several vaccinations are recommended especially for infants to provide at least some immunoprotection.

Besides the clinical diagnostics (long persisting cough with staccato cough attacks) the serological diagnostics is applied to determine the status of immunity (possibly after vaccination) and an acute infection. The new antigen PT-100 is used to standardize the recomLine Bordetella pertussis according to the WHO-standard and the guidelines of the German Robert-Koch-Institute. PT-100 detects an antibody titer >= 100 WHO units. A reactive PT-100 band corresponds with high probability to an acute infection when clinical symptoms appear (considering the vaccination managment).

The recomLine Bordetella pertussis IgG, IgA uses the antigens pertussis toxin (PT), specific for B. pertussis, and filamentous haemagglutinin (FHA) which all representatives of Bordetella species have in common.

After screening by ELISA the recomLine Bordetella pertussis IgG, IgA can be used for clarification of borderline and positive ELISA-results and for the determination of the actual immune status.

Research Use Only.

For Sale In the United States Only.

To purchase outside of the US, please contact Mikrogen.